EM CONSTRUÇÃO

 

BIBLIOTECA EM DISTROFIA MUSCULAR

 

Esta é uma página privada. Não há um link entre o site e esta página. O conteúdo desta página é protegido por direito autoral. Eu coloquei estas informações para uso pessoal. Por favor não publique nenhum destes artigos integrais em outros sites.

 

HISTÓRIA

The dystrophy of Duchenne

 

FOTOS E VÍDEOS DOS SINTOMAS E DA DOENÇA

Sinal de Gowers

Sinal de Gowers

Vídeo do Sinal de Gowers

Hipertrofia da panturrilha

Escoliose

Alterações do pé

Distrofina

DISTROFIA MUSCULAR DE DUCHENNE - REVISÕES

Duchenne muscular dystrophy and dystrophin:pathogenesis and opportunities for treatment

Molecular, cellular, and pharmacological therapies for Duchenne/Becker muscular dystrophies

CORTICÓIDES

Reflection and Reaction: Prednisone for Duchenne muscular dystrophy

ENMC steroids in DMD material

Intermittent Prednisone Therapy in Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy and Steroids: Pharmacologic Treatment in the Absence of Effective Gene Therapy

REPORT ON THE ROUND TABLE ON STEROIDS IN DUCHENNE MUSCULAR DYSTROPHY HELD IN MONTE CARLO ON JUNE 6, 2003

Practice Parameter: Corticosteroid treatment of Duchenne dystrophy

Deflazacort for the treatment of Duchenne Dystrophy: A systematic review

Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research

Prednisolone therapy in Duchenne muscular dystrophy prolongs ambulation and prevents scoliosis

Uso dos corticóides no tratamento da distrofia muscular de Duchenne

Corticosteroid Treatment and Functional Improvement in Duchenne Muscular Dystrophy

Deflazacort treatment of Duchenne muscular dystrophy

A MULTICENTER, DOUBLE-BLIND, RANDOMIZED TRIAL OF DEFLAZACORT VERSUS PREDNISONE IN DUCHENNE MUSCULAR DYSTROPHY

Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade

Glucocorticoid-mediated regulation of utrophin levels in human muscle fibers

High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy

 

 

 

TERAPIA GÊNICA E OLIGONUCLEOTÍDEOS

Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cells

Antisense-Induced Multiexon Skipping for Duchenne Muscular Dystrophy Makes More Sense

Exploring the Frontiers of Therapeutic Exon Skipping for Duchenne Muscular Dystrophy by Double Targeting within One or Multiple Exons

 

 

CÉLULAS TRONCO

Robust conversion of marrow cells to skeletal muscle with formation of marrow-derived muscle cell colonies: A multifactorial process

 

CARDIOMIOPATIAS NAS DISTROFIAS MUSCULARES

The Frank Vectorcardiogram and the Electrocardiogram in Duchenne Progressive Muscular Dystrophy

Cardiomyopathy in Muscular Dystrophy Workshop 28–30 September 2003, Tucson, Arizona

Tissue Doppler imaging detects early asymptomatic myocardial abnormalities in a dog model of Duchenne’s cardiomyopathy

Occult Cardiac Contractile Dysfunction in Dystrophin-Deficient Children Revealed by Cardiac Magnetic Resonance Strain Imaging

Cardiac assessment in childhood carriers of Duchenne and Becker muscular dystrophies

Cardiomyopathic features associated with muscular dystrophy are independent of dystrophin absence in cardiovasculature

Evidence of Early Impairments in Both Right and Left Ventricular Inotropic Reserves in Children With Duchenne’s Muscular Dystrophy

Electron microscopic findings of cardiomyopathy with limb girdle muscular dystrophy

107th ENMC International Workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th–9th June 2002, Naarden, the Netherlands

Cardiovascular Health Supervision for Individuals Affected by Duchenne or Becker Muscular Dystrophy

Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years’ follow-up

 

RESPIRAÇÃO NAS DISTROFIAS MUSCULARES

Duchenne Muscular Dystrophy:Prolongation of Life by NoninvasiveVentilation and Mechanically Assisted Coughing

Respiratory Care of the Patient with Duchenne Muscular Dystrophy - ATS Consensus Statement

Expiratory Flow Maneuvers in Patients with NeuromuscularDiseases

Trends in survival from muscular dystrophy in England and Wales and impact on respiratory services

Respiratory monitoring in neuromuscular disease — capnography as an additional tool?

Respiratory function in congenital muscular dystrophy and limb girdle muscular dystrophy 2I

The prognostic value of pre-operative predicted forced vital capacity in corrective spinal surgery for Duchenne’s muscular dystrophy

Daytime predictors of sleep disordered breathing in children and adolescents with neuromuscular disorders

117th ENMC Workshop: Ventilatory Support in Congenital Neuromuscular Disorders — Congenital Myopathies, Congenital Muscular Dystrophies, Congenital Myotonic Dystrophy and SMA (II) 4–6 April 2003, Naarden, The Netherlands

Diaphragmatic function in advanced Duchenne muscular dystrophy

Changes in Spirometry Over Time as a Prognostic Marker in Patients with Duchenne Muscular Dystrophy

Insuficiência respiratória crônica em pacientes com doença neuromuscular: diagnóstico e tratamento

 

ANESTESIA NAS DISTROFIAS MUSCULARES

Duchenne muscular dystrophy: an old anesthesia problem revisited

 

COMPORTAMENTO NAS DISTROFIAS MUSCULARES

Behavior patterns in Duchenne muscular dystrophy: Report on the Parent Project Muscular Dystrophy behavior workshop 8–9 of December 2006, Philadelphia, USA